Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
27,691,200
-
Total 13F shares
-
11,273,521
-
Share change
-
-148,651
-
Total reported value
-
$63,103,949
-
Put/Call ratio
-
213%
-
Price per share
-
$5.63
-
Number of holders
-
24
-
Value change
-
-$835,989
-
Number of buys
-
2
-
Number of sells
-
8
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q2 2022
As of 30 Jun 2022 FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) had 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,273,521 shares of stock of the company.
Largest 10 holders included Southpoint Capital Advisors LP, Sonic Fund II, L.P., DG Capital Management, LLC, Avoro Capital Advisors LLC, Solas Capital Management, LLC, 683 Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, HARBERT FUND ADVISORS, INC., Tamar Securities, LLC, and BlackRock Inc..
This table shows 24 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.